- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03278210
National Study on the Interest of EEG-fMRI in the Presurgical Evaluation of Partial Epilepsies Drug (ENERGY)
The main goal of this study is to evaluate the additional value of EEG-fMRI method in the presurgical evaluation of focal intractable epilepsy.
To consider a patient for surgery, the main difficulty is to define accurately the epileptogenic zone. This definition is complex and is often supported by several types of exploration (MRI, FDG PET, neuropsychological testing, video-EEG...). In this study we will evaluate the adding value of the simultaneous recording of EEG and fMRI in the epileptogenic zone definition.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Lille, France
- Hôpital Roger Salengro, CHRU de Lille
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- > 8 years old
- intractable focal epilepsy
- presurgical evaluation or "phase 1" planified
- with focal EEG activity : more than 3 EEG interictal epileptic events per hour
- patient and/or legal representant given their written consent for their participation in the study
Exclusion Criteria:
- MRI contraindication
- pregnancy
- uncomfortable prolonged lying position
- frequent primary or secondary generalised seizure with tonic clonic movements (>2 per week)
- previous epilepsy surgery
- important mental retardation
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
with EEG-fMRI data
EEG-fMRI was performed during the pre surgical evaluation, and its results were provided to the clinicians before surgery planification.
The final surgery strategy was decided with EEG-fMRI results.
|
|
without EEG-fMRI data
EEG-fMRI was performed during the pre surgical evaluation, but clinicians were blinded to the results.
The final surgery strategy was decided without EEG-fMRI results.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Efficacity of surgery measured by the International League Against Epilepsy (ILAE) scale
Time Frame: 1 year after surgery
|
A score between 1-4 reflects an improvement in epilepsy and between 5-6 a lack of improvement.
|
1 year after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patients who finally underwent a surgery after EEG-fMRI results even if they were considered as non surgical after standard presurgical evaluation
Time Frame: 1 year after surgery
|
1 year after surgery
|
|
|
Percentage of inter-ictal and ictal discharges for localizing the epileptogenic zone by EEG
Time Frame: 1 year after surgery
|
The percentage of non-localizing or lateralizing data (score 4 on the evaluation grid) will be calculated in relation to the total number of acquired victual data and compared with the equivalent percentage corresponding to the inter-state data.
|
1 year after surgery
|
|
Quality of life score (QOLIE 31)
Time Frame: 1 year after surgery
|
Comparison of the evolution of quality of life indices to 1 year of epilepsy surgery between the two groups using French versions of QOLIE 31 scales
|
1 year after surgery
|
|
Number of patients who finally underwent a surgery after EEG-fMRI results on SEEG implantation strategy after standard presurgical evaluation(concluded to a surgical management or an SEEG)
Time Frame: 1 year after surgery
|
1 year after surgery
|
|
|
Distinction of patients according to the type of their epilepsy: temporal / extra temporal.
Time Frame: 1 year after surgery
|
measure of the "type of epilepsy" effect on all the parameters studied re-evaluation of the points taking into account this distinction: main criterion, secondary criteria
|
1 year after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Louise Tyvaert, MD, PhD, University Hospital, Lille
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2009_54/1021
- 2010-A01101-38 (Other Identifier: ID-RCB number, ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Focal Epilepsy
-
Assistance Publique - Hôpitaux de ParisMedtronicRecruitingEpilepsy | Focal Epilepsy | Drug Resistant | Drug-resistant Focal Epilepsy | Epilepsies, FocalFrance
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
Peking Union Medical College HospitalGuidon Pharmaceutics Ltd.RecruitingRefractory Focal EpilepsyChina
-
Rapport Therapeutics Inc.RecruitingEpilepsy | Focal Epilepsy | Focal Onset Seizure | Seizure | Refractory Focal Epilepsy | Focal SeizureUnited States
-
Neuroelectrics CorporationCompletedEpilepsy | Seizures | Refractory Epilepsy | Epilepsy, Tonic-Clonic | Epilepsy in Children | Seizures, Focal | Focal SeizureSpain, United States, France, Belgium
-
Fondation Ophtalmologique Adolphe de RothschildRecruitingDrug Resistant Epilepsy | Pediatrics | Epilepsies, FocalFrance
-
BiocodexCompletedPharmacoresistant Focal EpilepsiesFrance
-
UCB Biopharma SRLTerminatedAn Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyHighly Drug-resistant Focal EpilepsyBelgium, Bulgaria, Germany, Hungary, Netherlands, Spain
-
UCB Biopharma S.P.R.L.PRA Health SciencesCompletedHighly Drug-resistant Focal EpilepsyBelgium, Bulgaria, Germany, Hungary, Netherlands, Spain
-
Azienda Ospedaliero-Universitaria di ModenaOspedale Pediatrico Bambino Gesù, Rome (IT); Azienda Sanitaria Universitaria... and other collaboratorsRecruitingEpileptic Encephalopathy | Epilepsies, Focal | EpilepsiesItaly